Results 101 to 110 of about 25,056 (120)

The Clinical Landscape of HDAC Inhibitors

Medical Epigenetics, 2021
Arasu Ganesan
exaly  

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2021
Shyamala C Navada
exaly  

Multidisciplinary Considerations in the Maintenance Treatment of Poly(ADP-Ribose) Polymerase Inhibitors for Homologous Recombination-Proficient, Advanced-Stage Epithelial Ovarian Cancer

Ca-A Cancer Journal for Clinicians, 2023
Ilana Css
exaly  

Histone Deacetylase Inhibitors in Medical Therapeutics

Medical Epigenetics, 2021
exaly  

Immune Checkpoint Inhibitors May Be Safe for Patients With Preexisting Autoimmune Disease

Ca-A Cancer Journal for Clinicians, 2020
Mike Fillon
exaly  

Epigenetics of Pain Management

Medical Epigenetics, 2021
Beverley Greenwood-Van Meerveld
exaly  

Poly(ADP-Ribose) Polymerase (PARP) Inhibitors: Exploiting a Synthetic Lethal Strategy in the Clinic

Ca-A Cancer Journal for Clinicians, 2011
Johann de Bono, Timothy A Yap, Shahneen K Sandhu   +2 more
exaly  

Experimental Approaches Toward Histone Acetyltransferase Modulators as Therapeutics

Medical Epigenetics, 2021
exaly  

Few Physicians Prescribe 5-Alpha Reductase Inhibitors for Prostate Cancer Prevention

Ca-A Cancer Journal for Clinicians, 2011
Mary Kay Barton
exaly  

Outcome of Combining Epigenetic Drugs With Other Treatments in the Clinic

Medical Epigenetics, 2016
Paromita Raha
exaly